Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Corvus Pharmaceuticals Inc buy Cantor Fitzgerald

Corvus Pharmaceuticals Inc
Start price
€7.16
11.12.25 / 50%
Target price
-
11.12.26
Performance (%)
-0.28%
Price
€7.11
11.12.25
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc is nearly unchanged. This prediction currently runs until 11.12.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w
Corvus Pharmaceuticals Inc -0.28%
iShares Core DAX® 0.734%
iShares Nasdaq 100 -2.686%
iShares Nikkei 225® -2.261%
iShares S&P 500 -1.346%

Comments by Cantor_Fitzgerald for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren

Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat

Cantor Fitzgerald 
0
Report Share
11.12.25 Buy -0.28%

Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.67
01.04.24
-
01.04.25
71.74%
02.04.25

Cantor Fitzgerald 
01.04.24 50%
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.51
07.09.23
€3.74
07.09.24
146.36%
08.09.24

Cantor Fitzgerald 
07.09.23 50%